Treatment with constitutive androstane receptor ligand during pregnancy prevents insulin resistance in offspring from high-fat diet-induced obese pregnant mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 2, 2012, Pages

  Masuyama, Hisashi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adipocytokine; Constitutive androstane receptor; Epigenetic change; Insulin resistance

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; ADIPOCYTOKINE; ADIPONECTIN; CONSTITUTIVE ANDROSTANE RECEPTOR; LEPTIN; MESSENGER RNA; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; FEMALE; GLUCOSE TOLERANCE; HYPERLIPIDEMIA; HYPERTENSION; IMMATURITY; INSULIN RESISTANCE; LIPID DIET; METABOLIC SYNDROME X; MOUSE; NEWBORN; NONHUMAN; OBESITY; PREGNANCY; PRIORITY JOURNAL; PROGENY; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ANIMALS; DIET, HIGH-FAT; FEMALE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LEPTIN; MICE; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PYRIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRIGLYCERIDES;

EID: 84863884021     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00167.2012     Document Type: Article

References (35)

1. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 23: 381-389, 2000.
2. Boney CM, Verma A, Tucker R, Vohr BS. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes. Pediatrics 115: e290-e296, 2005.
3. Catalano PM, Ehrenberg HM. The short-and long-term implications of maternal obesity on the mother and her offspring. BJOG 113: 1126-1133, 2006.
4. Choi SW, Friso S. Epigenetics: a new bridge between nutrition and health. Adv Nutr (Bethesda) 1: 8-16, 2010.
5. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 338: 147-152, 1998.
6. di Masi A, De Marinis E, Ascenzi P, Marino M. Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects. Mol Aspects Med 30: 297-343, 2009.
7. Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, Wakil SJ, Stevens RD, Ilkayeva O, Newgard CB, Chan L, Moore DD. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA 106: 18831-18836, 2009.
8. Gao J, He J, Zhai Y, Wada T, Xie W. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 284: 25974-25992, 2009.
9. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23: 963-974, 2004.
10. Gniuli D, Calcagno A, Caristo ME, Mancuso A, Macchi V, Mingrone G, Vettor R. Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny. J Lipid Res 49: 1936-1945, 2008.
11. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 30: 2287-2292, 2007.
12. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in men. Diabetologia 28: 401-411, 1985.
13. Inagaki T, Tachibana M, Magoori K, Kudo H, Tanaka T, Okamura M, Naito M, Kodama T, Shinkai Y, Sakai J. Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells 14: 991-1001, 2009.
14. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43: 1318-1323, 2004.
15. Jansson N, Nilsfelt A, Wennergren M, Rossander-Hulthen L, Powell TL, Jansson T. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr 87: 1743-1749, 2008.
16. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556, 2004.
17. Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62: 638-646, 2002.
18. Masuyama H, Hiramatsu Y. Effects of a high fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expressions. Endocrinology 2012 (published online before print March 20, 2012, doi: 10.1210/ en.2011-2161).
19. Masuyama H, Hiramatsu Y. Potential role of estradiol and progesterone in insulin resistance through constitutive androstane receptor. J Mol Endocrinol 47: 229-239, 2011.
20. Masuyama H, Hiramatsu Y. Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in high-fat dietinduced obese pregnant mice. Mol Cell Endocrinol 348: 120-127, 2012.
21. Moses RG, Luebcke M, Davis WS, Coleman KJ, Tapsell LC, Petocz P, Brand-Miller JC. Effect of a low-glycemic-index diet during pregnancy on obstetric outcomes. Am J Clin Nutr 84: 807-812, 2006.
22. Musri MM, Corominola H, Casamitjana R, Gomis R, Párrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem 281: 17180-17188, 2006.
23. Myers MG Jr. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 59: 287-304, 2004.
24. Qiu J. Epigenetics: unfinished symphony. Nature 441: 143-145, 2006.
25. Sakurai N, Mochizuki K, Gosa T. Modification of Histone H3 at Lysine 9 on the adiponectin Gene in 3T3-L1 adipocytes. J Nutr Sci Vitaminol 55: 131-138, 2009.
26. Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EH, Piersma AH, Ozanne SE, Twinn DF, Remacle C, Rowlerson A, Poston L, Taylor PD. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension 51: 383-392, 2008.
27. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y. Hypoadiponectinaemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88: 3236-3240, 2003.
28. Strakovsky RS, Zhang X, Zhou D, Pan YX. Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase gene expression and histone modification in neonatal offspring rats. J Physiol 589: 2707-2717, 2011.
29. Sugihara S, Sasaki N, Amemiya S, Kohno H, Tanaka T, Matsuura N. Analysis of weight at birth and at diagnosis of childhood-onset type 2 diabetes mellitus in Japan. Pediatr Diabetes 9: 285-290, 2008.
30. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, Lam KS. Hypoadiponectinaemia is associated with impaired endothelium-dependent vasodilatation. J Clin Endocrinol Metab 89: 765-769, 2004.
31. Tateishi K, Okada Y, Kallin EM, Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458: 757-761, 2009.
32. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE, Heijmans BT. DNA methylation differences after exposure to prenatal famine are common and timing-and sex-specific. Hum Mol Genet 18: 4046-4053, 2009.
33. van Schothorst EM, Bunschoten A, Schrauwen P, Mensink RP, Keijer J. Effects of a high-fat, low-versus high-glycemic index diet: retardation of insulin resistance involves adipose tissue modulation. FASEB J 23: 1092-1101, 2009.
34. Wakabayashi K, Okamura M, Tsutsumi S, Nishikawa NS, Tanaka T, Sakakibara I, Kitakami J, Ihara S, Hashimoto Y, Hamakubo T, Kodama T, Aburatani H, Sakai J. The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol 29: 3544-3555, 2009.
35. Yokomori N, Tawata M, Onaya T. DNA demethylation modulates mouse leptin promoter activity during the differentiation of 3T3-L1 cells. Diabetologia 45:140-148, 2002.